Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging Technology
TL;DR: The current intraoperative optical molecular imaging technologies, focusing on contrast agents and surgical navigation systems, and the future prospects of multi-modality imaging technology for intraoperative imaging-guided cancer surgery are reviewed.
read more
Abstract: Cancer is a major threat to human health. Diagnosis and treatment using precision medicine is expected to be an effective method for preventing the initiation and progression of cancer. Although anatomical and functional imaging techniques such as radiography, computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) have played an important role for accurate preoperative diagnostics, for the most part these techniques cannot be applied intraoperatively. Optical molecular imaging is a promising technique that provides a high degree of sensitivity and specificity in tumor margin detection. Furthermore, existing clinical applications have proven that optical molecular imaging is a powerful intraoperative tool for guiding surgeons performing precision procedures, thus enabling radical resection and improved survival rates. However, detection depth limitation exists in optical molecular imaging methods and further breakthroughs from optical to multi-modality intraoperative imaging methods are needed to develop more extensive and comprehensive intraoperative applications. Here, we review the current intraoperative optical molecular imaging technologies, focusing on contrast agents and surgical navigation systems, and then discuss the future prospects of multi-modality imaging technology for intraoperative imaging-guided cancer surgery.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer
Chen Zhang,Hongyan Cheng,Sha Dou,Yuanfen Wang,Xue Ye,Heng Cui,Xiaohong Chang,Yi Li +7 more
TL;DR: Researchers developed a near-infrared fluorescent probe using cetuximab to target EGFR-expressing epithelial ovarian cancer cells, demonstrating its feasibility for in vivo fluorescence imaging-guided surgery with potential for improved tumor detection and treatment.
Nanomedicine in Cancer
Liang Ma,Phuong Le,Manish Kohli,Andrew M. Smith +3 more
- 01 Jan 2019
TL;DR: A broad overview of the applications of nanotechnology in cancer medicine can be found in this article, where the fundamental physics and chemistry of different classes of nanoparticles are first described to detail the origin of their useful emergent properties in the context of current needs and standard clinical practices.
Multimodal laparoscopic coincidence gamma imaging system for near-infrared fluorescence guided surgery: a preclinical study
TL;DR: In this paper , a multimodal imaging system consisting of a laparoscopic module, containing an internal detector for annihilation gamma events and cameras for optical imaging, and a flat module for coincidence detection with the internal detector was evaluated.
References
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes.
TL;DR: In vivo imaging showed a 12-fold increase in NIRF signal, allowing the detection of tumors with submillimeter-sized diameters, and this strategy can be used to detect such early stage tumors in vivo and to probe for specific enzyme activity.
1.7K
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
Gooitzen M. van Dam,George Themelis,Lucia M. A. Crane,Niels J. Harlaar,Niels J. Harlaar,Rick G. Pleijhuis,W. Kelder,Athanasios Sarantopoulos,Johannes S. de Jong,Henriette J. G. Arts,Ate G.J. van der Zee,Joost Bart,Philip S. Low,Vasilis Ntziachristos +13 more
TL;DR: In patients with ovarian cancer, intraoperative tumor-specific fluorescence imaging with an FR-α–targeted fluorescent agent showcased the potential applications in patients with Ovarian cancer for improved intraoperative staging and more radical cytoreductive surgery.
1.5K
Image-guided cancer surgery using near-infrared fluorescence.
Alexander L. Vahrmeijer,Merlijn Hutteman,Joost R. van der Vorst,Cornelis J. H. Van De Velde,John V. Frangioni +4 more
TL;DR: The concept of NIR fluorescence imaging for cancer surgery is introduced, the clinical trial literature to date is examined, and the key issues pertaining to imaging system and contrast agent optimization are outlined.
A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle
Moritz F. Kircher,Adam de la Zerda,Jesse V. Jokerst,Cristina Zavaleta,Paul J. Kempen,Erik Mittra,Kenneth L. Pitter,Ruimin Huang,Carl Campos,Frezghi Habte,Robert Sinclair,Cameron Brennan,Ingo K. Mellinghoff,Ingo K. Mellinghoff,Eric C. Holland,Sanjiv S. Gambhir +15 more
TL;DR: It is shown that a unique triple-modality magnetic resonance imaging–photoacoustic imaging–Raman imaging nanoparticle approach can accurately help delineate the margins of brain tumors in living mice both preoperatively and intraoperatively.
What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer
Iris D. Nagtegaal,Phil Quirke +1 more
TL;DR: It is demonstrated that, after neoadjuvant therapy (both radiotherapy and radiochemotherapy), the predictive value of the CRM for local recurrence is significantly higher than when no preoperative therapy has been applied and involvement is one of the key factors in rectal cancer treatment.
1K